Treatment of glucantim™-resistant cutaneous leishmaniasis using combination therapy of allopurinol and trichloroacetic acid (TCA) 50; report of three cases

(2017) Treatment of glucantim™-resistant cutaneous leishmaniasis using combination therapy of allopurinol and trichloroacetic acid (TCA) 50; report of three cases. Journal of Isfahan Medical School. pp. 1318-1322. ISSN 10277595 (ISSN)

Full text not available from this repository.

Abstract

Background: Cutaneous leishmaniasis is endemic in 97 countries. If there is no remission with Glucantim as a choice of drug, other treatments such as cryotherapy and thermotherapy methods are used or other drugs such as allopurinol, pentamidine and amphotericin are prescribed. The use of trichloroacetic acid (TCA) 50 solution is another effective treatment. Case Report: We report three cases (two women and one man) of cutaneous leishmaniasis resistant to Glucantim treated with combination therapy of allopurinol and TCA 50. Conclusion: According to the results, the use of combination therapy of allopurinol and TCA 50 could be used as one of the alternative treatments in Glucantim™-resistant cutaneous leishmaniasis. © 2017, Isfahan University of Medical Sciences(IUMS). All rights reserved.

Item Type: Article
Keywords: Allopurinol Cutaneous leishmaniasis Glucantim Trichloroacetic acid (TCA) 50 amphotericin meglumine antimonate pentamidine trichloroacetic acid Article case report cryotherapy female human male skin leishmaniasis systematic review (topic) thermotherapy
Divisions: Skin Diseases and Leishmaniasis Research Center
Page Range: pp. 1318-1322
Journal or Publication Title: Journal of Isfahan Medical School
Journal Index: Scopus
Volume: 34
Number: 405
ISSN: 10277595 (ISSN)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/2076

Actions (login required)

View Item View Item